- Home
- BLRX vs YOTA Comparison
BLRX vs YOTA Comparison
Compare BLRX & YOTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- YOTA
- Stock Information
- Founded
- BLRX 2003
- YOTA 2021
- Country
- BLRX Israel
- YOTA United States
- Employees
- BLRX N/A
- YOTA N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- YOTA Farming/Seeds/Milling
- Sector
- BLRX Health Care
- YOTA Consumer Staples
- Exchange
- BLRX Nasdaq
- YOTA Nasdaq
- Market Cap
- BLRX 54.1M
- YOTA 43.6M
- IPO Year
- BLRX 2011
- YOTA 2022
- Fundamental
- Price
- BLRX $0.46
- YOTA $11.06
- Analyst Decision
- BLRX Strong Buy
- YOTA
- Analyst Count
- BLRX 2
- YOTA 0
- Target Price
- BLRX $11.50
- YOTA N/A
- AVG Volume (30 Days)
- BLRX 202.4K
- YOTA 946.0
- Earning Date
- BLRX 11-18-2024
- YOTA 01-01-0001
- Dividend Yield
- BLRX N/A
- YOTA N/A
- EPS Growth
- BLRX N/A
- YOTA 674.22
- EPS
- BLRX N/A
- YOTA 0.28
- Revenue
- BLRX $17,048,000.00
- YOTA N/A
- Revenue This Year
- BLRX N/A
- YOTA N/A
- Revenue Next Year
- BLRX N/A
- YOTA N/A
- P/E Ratio
- BLRX N/A
- YOTA $39.60
- Revenue Growth
- BLRX N/A
- YOTA N/A
- 52 Week Low
- BLRX $0.44
- YOTA $10.35
- 52 Week High
- BLRX $1.93
- YOTA $15.49
- Technical
- Relative Strength Index (RSI)
- BLRX 23.64
- YOTA 37.46
- Support Level
- BLRX $0.50
- YOTA $11.09
- Resistance Level
- BLRX $0.56
- YOTA $11.08
- Average True Range (ATR)
- BLRX 0.05
- YOTA 0.00
- MACD
- BLRX -0.01
- YOTA 0.00
- Stochastic Oscillator
- BLRX 10.60
- YOTA 0.00
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About YOTA Yotta Acquisition Corporation
Yotta Acquisition Corp is a shell company.